Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Emerging Tests-dtet
ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis
From - Diagnostic Testing & Emerging Technologies
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…
Paper-Based Test May Increase Male Fertility Self-Testing
...
Already a member? Log in here
Cost Effectiveness of Nail Fungus Confirmatory Test Treatment-Specific
...
Already a member? Log in here
Rise in Lyme Cases Drives Interest in New Tests
...
Already a member? Log in here
With Flu Epidemic, Better Diagnostics Become Focus
...
Already a member? Log in here
- « Previous
- 1
- …
- 22
- 23
- 24